Co-founder / Managing Partner
Data Science driven investment fund focused on strategically-timed investments at the inflection point of technological megatrends, investing in the synergetic convergence of specific DeepTech verticals. The fund is internationally renowned for its use of sophisticated analytical systems for investment target identification and due-diligence.
Longevity.Capital is a specialized Longevity Industry Index Hedge Fund with enhanced liquidity that uses hybrid investment technologies to combine the profitability of venture funds with the liquidity of hedge funds, significantly de-risking the interests of LPs and providing the best and most promising Longevity companies with relevant amounts of investment.
A leading Deep Tech analytical agency focused on AI, Longevity, Crypto Economy, and Convergence of Technological MegaTrends.
The mastermind nexus behind the corporate knowledge and intelligence of the Deep Knowledge Group.
Dmitry is well known for his support of life extension think-tanks in Oxford and Cambridge and many other related non-profit activities. He is the Managing Trustee of the Biogerontology Research Foundation, a UK charity expediting the coming paradigm shift from disease treatment to personalized precision prevention.
Aging Analytics Agency is the world’s premier provider of industry analytics on the topics of Longevity, Precision Preventive Medicine and Economics of Aging, and the convergence of technologies such as AI, Blockchain, Digital Health and their impact on the healthcare industry. The company provides strategic consulting services in fields relating to Longevity, and currently serves as the primary source of analytics and data for the UK All-Party Parliamentary Group for Longevity
Longevity International UK
Head of International Development
Longevity International is a social enterprise bringing together start-ups, industry, academic and governmental stakeholders under one umbrella to provide a unified voice and coordinating vehicle for positive discourse and change to ensure the ‘longevity dividend’ is accessible to everyone. Its first geographic focus is the United Kingdom.
Deep Knowledge Ventures flagship portfolio company. A leading company applying AI and Deep Learning for drug discovery development of biomarkers of aging.
Member of the Board